Cancer targeting by TCR gene-engineered T cells directed against Kita-Kyushu Lung Cancer Antigen-1

T cell receptor (TCR) gene-engineered T cells have shown promise in the treatment of melanoma and synovial cell sarcoma, but their application to epithelial cancers has been limited. The identification of novel therapeutic TCRs for the targeting of these tumors is important for the development of ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcinkowski, Bridget, Stevanović, Sanja, Helman, Sarah R., Norberg, Scott M., Serna, Carylinda, Jin, Benjamin, Gkitsas, Nikolaos, Kadakia, Tejas, Warner, Andrew, Davis, Jeremy L., Rooper, Lisa, Hinrichs, Christian S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712783/
https://www.ncbi.nlm.nih.gov/pubmed/31455429
http://dx.doi.org/10.1186/s40425-019-0678-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712783/
https://www.ncbi.nlm.nih.gov/pubmed/31455429
http://dx.doi.org/10.1186/s40425-019-0678-x

Ejemplares similares